PubChem BioAssays 1063:一个被充分利用的新抗莱什曼化合物来源
Sergio Sifontes-Rodríguez1, Susana Meneses-Gómez2, Alma Reyna Escalona-Montaño1
1Faculty of Medicine, National Autonomous University of Mexico, UNAM-INC Research Unit, National Institute of Cardiology "Ignacio Chávez", Mexico City, Mexico.
Journal of parasitology research
|July 7, 2025
概括
研究人员从一个大型化合物库中确定了强大的抗莱什曼药物候选药物. 这些精选的化合物在体外和体内表现出对Leishmania寄生虫的高疗效,突出显示了新治疗方法的宝贵资源.
科学领域:
- 药用化学 医学化学
- 寄生虫学的寄生虫学
- 药物发现 药物发现 药物发现
背景情况:
- 在PubChem生物测试 (AID 1063) 数据库中,包含了超过196,000种化合物的体外查数据,用于对抗*Leishmania major*前列腺炎.
- 尽管这些数据自2008年以来一直可用,但对有前途的化合物的进一步研究是有限的.
研究的目的:
- 从PubChem Bioassays (AID 1063) 数据集中选择和评估高活性化合物,以确定它们的抗莱什曼病潜力.
- 评估被选中的候选药物的体外和体内疗效,以对抗各种*Leishmania*物种.
主要方法:
- 化合物被选定基于100%的活性在10μM的初级测试,预测的低毒性,有利的药物相似性,以及没有泛测试干扰结构特征.
- 七种商用化合物对*L. major*, *L. mexicana*, *L. amazonensis*和*L. infantum*促性菌进行了测试,对小鼠巨细胞毒性进行了评估,并对细胞内*L. mexicana*促性菌进行了评估.
- 四种有前途的化合物进一步在皮肤莱什曼病的小鼠模型中通过内注射进行了测试.
主要成果:
- 四种选定的化合物表现出强烈的活性 (IC50 < 10μM) 对所有四种测试的 *Leishmania* 种类的前虫阶段.
- 这些化合物还显示出显著的体外活性对细胞内巨菌和体内有效性在感染L. mexicana的小鼠模型.
- 选择的化合物表现出适当的选择性和对*L. mexicana* amastigotes的高活性.
结论:
- 这项研究成功地确定了四种强大的抗莱什曼尼化合物,这些化合物有进一步开发的潜力.
- 该PubChem生物测试 (AID 1063) 数据集代表了一个丰富的,但尚未探索的资源,用于发现新型抗莱什曼尼毒剂.
关键词:
1063 援助 援助 1063 援助在BALB/c小鼠中.莱什曼亚亚马逊菌 (Leishmania amazonensis) 是一种亚马逊亚洲菌.莱什曼尼亚婴儿病 (英语:Leishmania infantum) 是一种疾病.莱什曼尼亚大型 (Leishmania major) 是一个很大的病.墨西哥的莱什马尼亚.皮肤上的莱什曼病.细胞内部的阿马斯蒂哥特.促成激烈的运动.更多相关视频
08:48Development of a Backbone Cyclic Peptide Library as Potential Antiparasitic Therapeutics Using Microwave Irradiation
Published on: January 26, 2016
12.0K
12:02An Efficient Method for the Synthesis of Peptoids with Mixed Lysine-type/Arginine-type Monomers and Evaluation of Their Anti-leishmanial Activity
Published on: November 2, 2016
12.2K
相关概念视频
01:30Leishmaniasis
Leishmaniasis is a protozoal disease caused by species of the genus Leishmania and transmitted through the bite of infected female sandflies. The parasite exists in two principal morphological forms during its life cycle. A sandfly acquires intracellular amastigotes from an infected reservoir host, such as a dog. Within the sandfly, these forms differentiate into motile, flagellated promastigotes. During a subsequent blood meal, promastigotes are injected into the human host, where they...
01:21Antiprotozoal Agents
Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...